MD SB1039 | 2019 | Regular Session


Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 4 2019 - 25% progression
Action: 2019-03-20 - Unfavorable Report by Finance; Withdrawn
Text: Latest bill text (Introduced) [PDF]


Requiring the Maryland Medical Assistance Program to establish reimbursement levels, rather than maximum reimbursement levels, for certain drug products; requiring that certain minimum reimbursement levels be at least equal to the National Average Drug Acquisition Cost of the generic product plus a certain fee-for-service professional dispensing fee; providing that certain provisions of the Act apply to managed care organizations that use pharmacy benefits managers to manage prescription drug coverage; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.


Maryland Medical Assistance Program and Managed Care Organizations That Use Pharmacy Benefits Managers - Reimbursement Requirements



2019-03-20SenateUnfavorable Report by Finance; Withdrawn
2019-03-18SenateHearing canceled
2019-03-15SenateHearing 3/19 at 1:00 p.m.
2019-03-14SenateRereferred to Finance
2019-03-04SenateFirst Reading Senate Rules


Maryland State Sources

Bill Comments